» Articles » PMID: 31808119

Roux-en-Y Gastric Bypass As a Treatment for Barrett's Esophagus After Sleeve Gastrectomy

Overview
Journal Obes Surg
Date 2019 Dec 7
PMID 31808119
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Laparoscopic sleeve gastrectomy (SG) is the most frequently performed bariatric procedure today. While an increasing number of long-term studies report the occurrence of Barrett's esophagus (BE) after SG, its treatment has not been studied, yet.

Objectives: The aim of this study was to evaluate Roux-en-Y gastric bypass (RYGB) as treatment for BE and reflux after SG.

Setting: University hospital setting, Austria METHODS: This multi-center study includes all patients (n = 10) that were converted to RYGB due to BE after SG in Austria. The mean interval between SG and RYGB was 42.7 months. The follow-up after RYGB in this study was 33.4 months. Gastroscopy, 24 h pH-metry, and manometry were performed and patients were asked to complete the BAROS and GIQLI questionnaires.

Results: Weight and BMI at the time of SG was 120.8 kg and 45.1 kg/m. Eight patients (80.0%) went into remission of BE after the conversion to RYGB. Two patients had RYGB combined with hiatoplasty. The mean acid exposure time in 24 h decreased from 36.8 to 3.8% and the mean DeMeester score from 110.0 to 16.3. Patients scored 5.1 on average in the BAROS after conversion from SG to RYGB which denotes a very good outcome.

Conclusions: RYGB is an effective therapy for patients with BE and reflux after SG. Its outcomes in the current study were BE remission in the majority of cases as well as a decrease in reflux activity. Further studies with larger cohorts are necessary to confirm these findings.

Citing Articles

Bariatric surgery and relevant comorbidities: a systematic review and meta-analysis.

Wunker C, Kumar S, Hallowell P, Collings A, Loss L, Bansal V Surg Endosc. 2025; 39(3):1419-1448.

PMID: 39920373 PMC: 11870965. DOI: 10.1007/s00464-025-11528-4.


RESULTS OF MECHANIC VERSUS MOTORIZED STAPLER USED IN GASTRIC SURGERY: PROSPECTIVE STUDY.

Braghetto I, Czwiklitzer G, Korn O, Brante P, Burgos A Arq Bras Cir Dig. 2024; 37:e1818.

PMID: 39230118 PMC: 11363907. DOI: 10.1590/0102-6720202400025e1818.


Challenges of Revisional Metabolic and Bariatric Surgery: A Comprehensive Guide to Unraveling the Complexities and Solutions of Revisional Bariatric Procedures.

Evans L, Castillo-Larios R, Cornejo J, Elli E J Clin Med. 2024; 13(11).

PMID: 38892813 PMC: 11172990. DOI: 10.3390/jcm13113104.


Reflux, Barrett's Esophagus, and Esophageal Adenocarcinoma After Bariatric Surgery.

Medina B, Molena D Foregut. 2024; 1(4):393-400.

PMID: 38646141 PMC: 11031263. DOI: 10.1177/26345161211068367.


GERD after Bariatric Surgery: A Review of the Underlying Causes and Recommendations for Management.

Pletch A, Lidor A Curr Gastroenterol Rep. 2024; 26(4):99-106.

PMID: 38353898 DOI: 10.1007/s11894-024-00919-7.


References
1.
Levine D, Blount P, Rudolph R, Reid B . Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus. Am J Gastroenterol. 2000; 95(5):1152-7. DOI: 10.1111/j.1572-0241.2000.02002.x. View

2.
Gagner M . Is Sleeve Gastrectomy Always an Absolute Contraindication in Patients with Barrett's?. Obes Surg. 2015; 26(4):715-7. DOI: 10.1007/s11695-015-1983-1. View

3.
Hirth D, Jones E, Rothchild K, Mitchell B, Schoen J . Laparoscopic sleeve gastrectomy: long-term weight loss outcomes. Surg Obes Relat Dis. 2015; 11(5):1004-7. DOI: 10.1016/j.soard.2015.02.016. View

4.
Arman G, Himpens J, Dhaenens J, Ballet T, Vilallonga R, Leman G . Long-term (11+years) outcomes in weight, patient satisfaction, comorbidities, and gastroesophageal reflux treatment after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016; 12(10):1778-1786. DOI: 10.1016/j.soard.2016.01.013. View

5.
Kindel T, Oleynikov D . The Improvement of Gastroesophageal Reflux Disease and Barrett's after Bariatric Surgery. Obes Surg. 2016; 26(4):718-20. DOI: 10.1007/s11695-016-2116-1. View